SG11201907045WA - Hafnocene catalyst compounds and process for use thereof - Google Patents
Hafnocene catalyst compounds and process for use thereofInfo
- Publication number
- SG11201907045WA SG11201907045WA SG11201907045WA SG11201907045WA SG11201907045WA SG 11201907045W A SG11201907045W A SG 11201907045WA SG 11201907045W A SG11201907045W A SG 11201907045WA SG 11201907045W A SG11201907045W A SG 11201907045WA SG 11201907045W A SG11201907045W A SG 11201907045WA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- pct
- applicant
- rule
- co8f
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F17/00—Metallocenes
Abstract
AA. . fA - - `=• .` *••• TI) Productivity fig 41 hnur) 2000 • r f 1500 1000 51I N (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 23 August 2018 (23.08.2018) WIP0 I PCT Iiiimmoimiolollmonolomonmolomimoilomovois (10) International Publication Number WO 2018/151790 Al (51) International Patent Classification: C08F 4/6592 (2006.01) CO8F 10/02 (2006.01) C08F 4/642 (2006.01) C08F 2/38 (2006.01) CO8F 4/52 (2006.01) (21) International Application Number: PCT/US2017/068175 (22) International Filing Date: 22 December 2017 (22.12.2017) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 62/461,113 20 February 2017 (20.02.2017) US 17165523.6 07 April 2017 (07.04.2017) EP (71) Applicant: EXXONMOBIL CHEMICAL PATENTS INC. [US/US]; 5200 Bayway Drive, Baytown, TX 77520 (US). (72) Inventor: McCULLOUGH, Laughlin, G.; 2011 Golden Bay Lane, League City, TX 77573 (US). (74) Agent: BELL, Catherine, L. et al.; Exxonmobil Chemical Company, Law Department, P.O. Box 2149, Baytown, TX 77522-2149 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, (54) Title: HAFNOCENE CATALYST COMPOUNDS AND PROCESS FOR USE THEREOF Figure (57) : This invention relates to hafnium metallocene compounds having a group substituted at the 3 position of at least one 2o_siR,3 -R 20 -CR'3 cyclopentadienyl ring represented by the formula _R or where R 20 is a C1 to C4 hydrocarbyl and R' is a C1 to C20 c substituted or unsubstituted hydrocarbyl. [Continued on next page] WO 2018/151790 Al IMEDIMO DOI 01011MENOMOMMEHOHOMEMNIE TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Declarations under Rule 4.17: as to applicant's entitlement to apply for and be granted a patent (Rule 4.17(H)) as to the applicant's entitlement to claim the priority of the earlier application (Rule 4.17(iii)) Published: — with international search report (Art. 21(3))
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762461113P | 2017-02-20 | 2017-02-20 | |
EP17165523 | 2017-04-07 | ||
PCT/US2017/068175 WO2018151790A1 (en) | 2017-02-20 | 2017-12-22 | Hafnocene catalyst compounds and process for use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201907045WA true SG11201907045WA (en) | 2019-09-27 |
Family
ID=68062741
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201907045WA SG11201907045WA (en) | 2017-02-20 | 2017-12-22 | Hafnocene catalyst compounds and process for use thereof |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP3583137A4 (en) |
CN (1) | CN110312741B (en) |
BR (1) | BR112019016048B1 (en) |
SG (1) | SG11201907045WA (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6884748B2 (en) * | 2002-09-04 | 2005-04-26 | Univation Technologies, Llc | Process for producing fluorinated catalysts |
US6869903B2 (en) * | 2002-11-07 | 2005-03-22 | Univation Technologies, Llc | Synthesis of polymerization catalyst components |
US7238756B2 (en) * | 2003-10-15 | 2007-07-03 | Univation Technologies, Llc | Polymerization process and control of polymer composition properties |
US7645834B2 (en) * | 2005-04-29 | 2010-01-12 | Fina Technologies, Inc. | Catalyst system for production of polyolefins |
-
2017
- 2017-12-22 CN CN201780086769.1A patent/CN110312741B/en active Active
- 2017-12-22 SG SG11201907045WA patent/SG11201907045WA/en unknown
- 2017-12-22 BR BR112019016048-5A patent/BR112019016048B1/en active IP Right Grant
- 2017-12-22 EP EP17896464.9A patent/EP3583137A4/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP3583137A4 (en) | 2020-03-18 |
CN110312741A (en) | 2019-10-08 |
BR112019016048A2 (en) | 2020-03-31 |
CN110312741B (en) | 2022-03-15 |
BR112019016048B1 (en) | 2023-03-21 |
EP3583137A1 (en) | 2019-12-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201901700UA (en) | Biaryl compounds useful as immunomodulators | |
SG11201807426WA (en) | Immunomodulators | |
SG11201903857UA (en) | Antibodies to pd-1 and uses thereof | |
SG11201903908PA (en) | Novel substituted n-(3-fluoropropyl)-pyrrolidine compounds, processes for their preparation and therapeutic uses thereof | |
SG11201908640TA (en) | Pyrrolidinones and a process to prepare them | |
SG11202000333UA (en) | Bicyclic ketone compounds and methods of use thereof | |
SG11201807827VA (en) | Process for the preparation of pegylated drug-linkers and intermediates thereof | |
SG11201804890TA (en) | Bipyrazolyl derivatives useful for the treatment of autoimmune diseases | |
SG11201805001UA (en) | Method of treating influenza a | |
SG11201900633XA (en) | Piperidine cxcr7 receptor modulators | |
SG11201804587QA (en) | Isoindole compounds | |
SG11201806393QA (en) | Use of gabaa receptor modulators for treatment of itch | |
SG11201806424TA (en) | Therapeutic compounds | |
SG11201908325PA (en) | Process for the preparation of glucuronide drug-linkers and intermediates thereof | |
SG11201900361RA (en) | Methods of treating prostate cancer | |
SG11201901172QA (en) | A method for manufacturing a fuel component | |
SG11201900336YA (en) | Radioligands for imaging the ido1 enzyme | |
SG11201908091QA (en) | Aqueous anti-pd-l1 antibody formulation | |
SG11201805263TA (en) | Compositions and methods for detecting and treating esophageal cancer | |
SG11201803816RA (en) | Targeting of the formyl-peptide receptor 2/lipoxin a4 receptor (fpr2/alx) for treatment of heart disease | |
SG11201906778RA (en) | Improved methods for assessing risk of developing breast cancer | |
SG11201903091VA (en) | Quinoxaline compounds as type iii receptor tyrosine kinase inhibitors | |
SG11201805141QA (en) | Compositions and methods for detecting and treating gastric cancer | |
SG11201909906QA (en) | Organic compounds | |
SG11201908605XA (en) | Antifouling article |